Xiamen Innovax Biotech CO., LTD. (INNOVAX) is a wholly owned subsidiary of Beijing Wantai Biological Pharmaceutical Co., LTD., under the YangShengTang Group.
Established in 2005, INNOVAX, has been dedicating to provide high-quantity and affordable innovative vaccine for people in need to combat infectious disease, launched the world’s first Hepatitis E Vaccine--Hecolin® in China in October 2012.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.